Citigroup provided a market rating on Incyte stock.
1 report, 1 independent
Updated Jul 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup provided a market rating on Incyte stock.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Citigroup
American investment bank and financial services corporation
-
Incyte
American pharmaceutical company
Nothing else this week.
Related events
- Citigroup maintained a market outperform rating for Ethos Technologies Inc. on November 6, 2026.
- Citigroup upgraded its target price and gave a buy rating for Fortrea.
- Citigroup reiterated a market outperform rating for Capital Southwest Corporation.
- Citigroup issued a neutral rating on Genpact shares, while TD Cowen reduced its price target and set a buy rating.
- Citigroup operates in India's financial market and CRISIL rates asset-backed securities in India.